PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 1 month ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 1 month ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax Marchés Financiers Rapports Financiers Autorités Françaises Autorités Américaines
BRIEF published on 03/24/2025 at 08:35, 1 year 1 month ago Abivax Publie ses Résultats Financiers pour 2024 Résultats Financiers Biotechnologie Recherche Et Développement Trésorerie Essais Cliniques
BRIEF published on 03/24/2025 at 08:35, 1 year 1 month ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 1 month ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers pour l’exercice 2024. Trésorerie de 144,2 millions d’euros au 31 décembre 2024. Perspectives financières disciplinées Résultats Financiers Biotechnologie Abivax Trésorerie Perspectives Financières
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 1 month ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 1 month ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers annuels pour l'Exercice 2024, montrant une trésorerie de 144,2 millions d'euros finançant les activités jusqu'au T4 2025, avec des résultats top-line attendus au T3 2025 Résultats Financiers Abivax Trésorerie Rectocolite Hémorragique Phase 3 ABTECT
BRIEF published on 03/14/2025 at 15:21, 1 year 1 month ago JP Morgan Chase réduit sa participation dans ABIVAX Franchissement De Seuil Actions Abivax Réglementation JP Morgan Chase
BRIEF published on 03/14/2025 at 15:21, 1 year 1 month ago JP Morgan Chase Reduces Stake in ABIVAX Actions Abivax Regulation Threshold Crossing JP Morgan Chase
PRESS RELEASE published on 03/14/2025 at 15:16, 1 year 1 month ago Franchissement de seuil JP Morgan Chase & Co. a déclaré détenir 4,73% du capital d'ABIVAX indirectement. Détails des actions et contrats impliqués Déclaration Actions Abivax JP Morgan Chase & Co. Franchissement Seuil
Published on 05/08/2026 at 01:50, 1 hour 38 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 2 hours 43 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 3 hours 28 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 3 hours 58 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 4 hours 13 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 4 hours 4 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 4 hours 13 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 5 hours 22 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 6 hours 45 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 8 hours 42 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 8 hours 13 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 8 hours 13 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 8 hours 22 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 8 hours 22 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 8 hours 28 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
